User profiles for Edward J Wild

Prof Edward J Wild

Professor of Neurology, Huntington's Disease Centre, UCL Institute of Neurology
Verified email at ucl.ac.uk
Cited by 16374

Huntington disease

…, CA Ross, RI Scahill, R Wetzel, EJ Wild… - Nature reviews Disease …, 2015 - nature.com
Huntington disease is devastating to patients and their families—with autosomal dominant
inheritance, onset typically in the prime of adult life, progressive course, and a combination of …

Huntington disease: natural history, biomarkers and prospects for therapeutics

CA Ross, EH Aylward, EJ Wild, DR Langbehn… - Nature Reviews …, 2014 - nature.com
Huntington disease (HD) can be seen as a model neurodegenerative disorder, in that it is
caused by a single genetic mutation and is amenable to predictive genetic testing, with …

Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis

…, A Wallin, A Weiss, C Wikkelsø, EJ Wild… - JAMA …, 2019 - jamanetwork.com
Importance Neurofilament light protein (NfL) is elevated in cerebrospinal fluid (CSF) of a
number of neurological conditions compared with healthy controls (HC) and is a candidate …

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

M Björkqvist, EJ Wild, J Thiele, A Silvestroni… - The Journal of …, 2008 - rupress.org
Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by both
neurological and systemic abnormalities. We examined the peripheral immune system and …

[HTML][HTML] Targeting huntingtin expression in patients with Huntington's disease

…, BR Leavitt, GB Landwehrmeyer, EJ Wild… - … England Journal of …, 2019 - Mass Medical Soc
Background Huntington’s disease is an autosomal-dominant neurodegenerative disease
caused by CAG trinucleotide repeat expansion in HTT, resulting in a mutant huntingtin protein. …

Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities

SJ Tabrizi, MD Flower, CA Ross, EJ Wild - Nature Reviews Neurology, 2020 - nature.com
… iPSC)-derived neurons from individuals with HD to wild-type mouse brain slices, from HD …
wild-type mouse corticostriatal brain slice, and following injection of an mHTT fragment into wild

[HTML][HTML] Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

…, SJ Tabrizi, H Zetterberg, D Langbehn, EJ Wild - The Lancet …, 2017 - thelancet.com
Background Blood biomarkers of neuronal damage could facilitate clinical management of
and therapeutic development for Huntington's disease. We investigated whether …

Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities

…, MD Flower, RI Scahill, EJ Wild… - The Lancet …, 2022 - thelancet.com
Huntington's disease is the most frequent autosomal dominant neurodegenerative disorder;
however, no disease-modifying interventions are available for patients with this disease. …

[HTML][HTML] Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients

EJ Wild, R Boggio, D Langbehn… - The Journal of …, 2015 - Am Soc Clin Investig
BACKGROUND: Quantification of disease-associated proteins in the cerebrospinal fluid (CSF)
has been critical for the study and treatment of several neurodegenerative disorders; …

Therapies targeting DNA and RNA in Huntington's disease

EJ Wild, SJ Tabrizi - The Lancet Neurology, 2017 - thelancet.com
… might be impaired because mutant HTT functions less efficiently than wild-type HTT. For
example, the overexpression of wild-type HTT stimulates axonal vesicular transport of BDNF in …